Jilin Aodong Pharmaceutical Group Co Ltd Financial Flexibility Index
Jilin Aodong Pharmaceutical Group Co Ltd financial flexibility index. Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥137.92 Million (operating CF CN¥112.12 Million minus capex CN¥25.80 Million) represents 0% of total liabilities (CN¥3.76 Billion). See how much free cash does Jilin Aodong Pharmaceutical Group Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jilin Aodong Pharmaceutical Group Co Ltd (1998–2025)
Financial flexibility index of Jilin Aodong Pharmaceutical Group Co Ltd from 1998 to 2025. Historical Financial Flexibility Index trend for Jilin Aodong Pharmaceutical Group Co Ltd across 28 annual periods. Check earnings quality score of Jilin Aodong Pharmaceutical Group Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Jilin Aodong Pharmaceutical Group Co Ltd Financial Flexibility Index by Year (1998–2025)
Jilin Aodong Pharmaceutical Group Co Ltd financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Jilin Aodong Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see 000623 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.11x | CN¥400.71 Million | CN¥272.26 Million | CN¥3.53 Billion | ▲ +26.6% |
| 2024 | 0.09x | CN¥333.47 Million | CN¥59.48 Million | CN¥3.72 Billion | ▼ -12.4% |
| 2023 | 0.10x | CN¥487.58 Million | CN¥68.06 Million | CN¥4.77 Billion | ▼ -28.7% |
| 2022 | 0.14x | CN¥694.82 Million | CN¥423.86 Million | CN¥4.84 Billion | ▼ -9.4% |
| 2021 | 0.16x | CN¥638.15 Million | CN¥324.85 Million | CN¥4.03 Billion | ▼ -0.6% |
| 2020 | 0.16x | CN¥617.79 Million | CN¥390.41 Million | CN¥3.88 Billion | ▼ -11.1% |
| 2019 | 0.18x | CN¥601.85 Million | CN¥379.46 Million | CN¥3.36 Billion | ▲ +3.3% |
| 2018 | 0.17x | CN¥592.94 Million | CN¥347.64 Million | CN¥3.41 Billion | ▼ -32.8% |
| 2017 | 0.26x | CN¥340.41 Million | CN¥256.49 Million | CN¥1.32 Billion | ▼ -23.0% |
| 2016 | 0.34x | CN¥491.84 Million | CN¥333.81 Million | CN¥1.47 Billion | ▲ +4.5% |
| 2015 | 0.32x | CN¥722.14 Million | CN¥388.03 Million | CN¥2.25 Billion | ▼ -48.4% |
| 2014 | 0.62x | CN¥690.84 Million | CN¥288.83 Million | CN¥1.11 Billion | ▲ +22.7% |
| 2013 | 0.51x | CN¥510.22 Million | CN¥201.22 Million | CN¥1.01 Billion | ▲ +2.3% |
| 2012 | 0.50x | CN¥599.20 Million | CN¥272.40 Million | CN¥1.21 Billion | ▼ -13.6% |
| 2011 | 0.57x | CN¥566.02 Million | CN¥108.30 Million | CN¥985.86 Million | ▲ +14.8% |
| 2010 | 0.50x | CN¥326.22 Million | CN¥174.22 Million | CN¥652.43 Million | ▲ +20.6% |
| 2009 | 0.41x | CN¥249.54 Million | CN¥213.03 Million | CN¥601.83 Million | ▼ -1.3% |
| 2008 | 0.42x | CN¥266.55 Million | CN¥235.03 Million | CN¥634.74 Million | ▼ -26.2% |
| 2007 | 0.57x | CN¥423.94 Million | CN¥384.69 Million | CN¥744.94 Million | ▲ +119.5% |
| 2006 | 0.26x | CN¥244.87 Million | CN¥187.99 Million | CN¥944.28 Million | ▲ +12.1% |
| 2005 | 0.23x | CN¥191.94 Million | CN¥136.26 Million | CN¥829.84 Million | ▼ -22.2% |
| 2004 | 0.30x | CN¥264.72 Million | CN¥218.53 Million | CN¥890.13 Million | ▼ -25.5% |
| 2003 | 0.40x | CN¥239.54 Million | CN¥147.65 Million | CN¥600.19 Million | ▲ +219.0% |
| 2002 | 0.13x | CN¥76.32 Million | CN¥-4.58 Million | CN¥609.94 Million | ▼ -81.5% |
| 2001 | 0.68x | CN¥346.13 Million | CN¥138.76 Million | CN¥512.58 Million | ▼ -8.8% |
| 2000 | 0.74x | CN¥240.94 Million | CN¥77.04 Million | CN¥325.23 Million | ▲ +90.6% |
| 1999 | 0.39x | CN¥180.70 Million | CN¥110.18 Million | CN¥464.78 Million | ▲ +94.7% |
| 1998 | 0.20x | CN¥42.42 Million | CN¥-30.90 Million | CN¥212.43 Million | — |